- Home
- VYNE vs CMBM Comparison
VYNE vs CMBM Comparison
Compare VYNE & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- CMBM
- Stock Information
- Founded
- VYNE 2003
- CMBM 2011
- Country
- VYNE United States
- CMBM United States
- Employees
- VYNE N/A
- CMBM N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- VYNE Health Care
- CMBM Technology
- Exchange
- VYNE Nasdaq
- CMBM Nasdaq
- Market Cap
- VYNE 24.3M
- CMBM 26.5M
- IPO Year
- VYNE 2018
- CMBM 2019
- Fundamental
- Price
- VYNE $0.35
- CMBM $0.70
- Analyst Decision
- VYNE Buy
- CMBM Buy
- Analyst Count
- VYNE 2
- CMBM 1
- Target Price
- VYNE $8.00
- CMBM $3.00
- AVG Volume (30 Days)
- VYNE 4.1M
- CMBM 512.6K
- Earning Date
- VYNE 08-14-2025
- CMBM 08-26-2025
- Dividend Yield
- VYNE N/A
- CMBM N/A
- EPS Growth
- VYNE N/A
- CMBM N/A
- EPS
- VYNE N/A
- CMBM N/A
- Revenue
- VYNE $476,000.00
- CMBM $172,215,000.00
- Revenue This Year
- VYNE $42.51
- CMBM N/A
- Revenue Next Year
- VYNE N/A
- CMBM $17.73
- P/E Ratio
- VYNE N/A
- CMBM N/A
- Revenue Growth
- VYNE N/A
- CMBM N/A
- 52 Week Low
- VYNE $0.33
- CMBM $0.23
- 52 Week High
- VYNE $4.30
- CMBM $2.08
- Technical
- Relative Strength Index (RSI)
- VYNE 29.46
- CMBM 45.40
- Support Level
- VYNE $0.35
- CMBM $0.70
- Resistance Level
- VYNE $0.36
- CMBM $0.80
- Average True Range (ATR)
- VYNE 0.04
- CMBM 0.12
- MACD
- VYNE -0.02
- CMBM -0.04
- Stochastic Oscillator
- VYNE 1.79
- CMBM 5.34
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.